← Open Payments lookup

JENNIFER GARRISON: Open Payments

NPI 1710576905 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$804 in 38 payments from 12 companies in 2025. Trend: 2023 $132 · 2024 $645 · 2025 $804

Food & beverage: $804
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$286
AstraZeneca Pharmaceuticals LP5$150
ABBVIE INC.6$142
Otsuka America Pharmaceutical, Inc.4$57
Novo Nordisk Inc2$32
PFIZER INC.2$29
Bayer Healthcare Pharmaceuticals Inc.1$26
Amgen Inc.1$18
Lilly USA, LLC1$17
Currax Pharmaceuticals LLC1$16

Products named: CAPLYTA, VRAYLAR, BREZTRI, REXULTI, UBRELVY, NURTEC ODT, Kerendia, AIRSUPRA.

Industry payments across AL — which companies pay providers there.